Verano Holdings Takes Bold Step Forward with 1-for-5 Reverse Stock Split
Last Updated
Verano Holdings is charting an ambitious path with the successful completion of its 1-for-5 reverse split, designed to elevate share price and unlock greater institutional interest.
Chicago, June 15, 2026 — Verano Holdings Corp. has successfully completed its 1-for-5 reverse stock split, a significant milestone that demonstrates the company's aspiration to secure a coveted listing on a major U.S. stock exchange and increase its visibility in the rapidly changing cannabis industry.
Effective June 11, 2026, the reverse split consolidated every five pre-split shares into one, trimming issued and outstanding shares from about 367.7 million to roughly 73.9 million. Authorized shares were likewise reduced from 5 billion to 1 billion following a Nevada filing. The move, approved by the board and announced earlier in June, is already helping to lift the per-share price while preserving shareholders’ proportional ownership. Verano continues trading on Cboe Canada and OTCQX under its VRNO ticker.
As a dynamic multistate operator (MSO) with a powerful footprint across 13 states, Verano stands out for its fully vertically integrated model. The company operates a network of retail dispensaries under the respected Zen Leaf™ and MÜV™ brands, supported by 14 state-of-the-art production facilities and over 1.1 million square feet of cultivation capacity. Its impressive portfolio of consumer brands, including Savvy™, (the) Essence™, Swift Lifts™, HYPHEN™, Encore™, BITS™, Avexia™, CTPharma™, and Verano™, delivers high-quality products to both medical and adult-use customers across key markets.
This reverse split is far more than a technical adjustment; it’s a strategic catalyst designed to raise the share price, meet the stringent listing requirements of the NYSE or Nasdaq, and unlock broader appeal among institutional investors. By achieving a more attractive per-share valuation, Verano aims to enhance market presence, improve liquidity, and position itself for sustained growth in an industry on the cusp of transformation.
The timing couldn’t be better. With federal rescheduling efforts gaining momentum and potential regulatory relief on the horizon, including eased banking restrictions and meaningful 280E tax reform, Verano is well-placed to thrive. The company’s solid first-quarter 2026 revenue of $208 million highlights its operational strength and resilience, even as the sector navigates state-level challenges.
Following its 2025 redomestication from British Columbia to Nevada, Verano has been methodically laying the groundwork for deeper integration into U.S. capital markets. Executives see this latest move as building momentum toward greater institutional participation and long-term value creation for shareholders.
In a sector brimming with potential, Verano’s proactive approach reflects confidence in its scalable platform and diversified operations. As barriers continue to fall, the company is poised to emerge as a leading consolidator, capitalizing on expanding opportunities in medical cannabis and beyond.
Industry observers will be watching closely as Verano advances toward its uplisting goals. For investors and stakeholders, this forward momentum signals exciting times ahead for one of the cannabis industry’s most ambitious players.